longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

LFMDP

LFMDP
23.1490.22%( -0.051 )

LongbridgeAI

LifeMD Appoints Atul Kavthekar CFO As Marc Benathen Departs; Names Pisano CMO, Friedeman CBO

nasdaq
Mar 16, 2026 at 01:00 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

LifeMD Inc. has appointed Atul Kavthekar as CFO, effective immediately, following Marc Benathen's departure. Benathen will assist until March 31 for a smooth transition. Additionally, Chris Pisano has been named CMO, and Jessica Friedeman will serve as CBO. Kavthekar brings extensive financial leadership experience, while Pisano will manage marketing strategies. Friedeman will continue her role in women's health and lead new health offerings. In pre-market trading, LFMDP shares rose 7.28% to $4.2697.

(RTTNews) - LifeMD Inc. (LFMD, LFMDP) on Monday appointed Atul Kavthekar as chief financial officer, effective immediately, as current CFO Marc Benathen will depart to pursue another opportunity and remain with the company through March 31 to support the transition.

The company also announced leadership changes, appointing Chris Pisano as chief marketing officer and naming Jessica Friedeman as chief business officer.

Kavthekar brings nearly three decades of financial leadership experience across healthcare, pharmacy, e-commerce and technology companies, with expertise in capital markets, mergers and acquisitions, and strategic planning.

Pisano has more than 25 years of marketing experience across healthcare, financial services, technology and e-commerce, and will oversee the company's marketing organization, including brand strategy, digital marketing and market positioning.

Friedeman, who joined the company as chief marketing officer in January 2023, will lead the launch of LifeMD's enterprise and employer health offerings while continuing as general manager of the company's women's health division.

In the pre-market trading, LFMDP is trading 7.28% higher at $4.2697 on the Nasdaq.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Login to unlock835characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

LifeMD Pref Share LFMDP 8.875 Perp 10/15/22

LifeMD Pref Share LFMDP 8.875 Perp 10/15/22

LFMDP.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--